atherosclerosis

Cyclarity: When bad guy cells have a change of heart

Biotech Investment Investment Videos

Designing a molecule for longevity

Biotech Videos

The small molecule with a big future

Biotech Videos

Humacyte publishes 6-year outcomes in Phase 2 study of its Human Acellular Vessel

Biotech Investment

Making a noise about the silent killer

Biotech Investment

Cyclarity’s guardians are leading the battle against atherosclerosis

Biotech Investment Videos

Innovative atherosclerosis treatment readies for clinical trials

Biotech

Constructively disruptive – tackling atherosclerosis through disease reversal

Biotech Investment Videos

Underdog becomes Cyclarity – and moves to the Buck Institute

Biotech Investment